Diagnosis, clinical course, and 1-year outcome in patients hospitalized for heart failure with preserved ejection fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry)
| UDC.coleccion | Investigación | es_ES |
| UDC.endPage | 542 | es_ES |
| UDC.grupoInv | Insuficiencia Cardíaca Avanzada e Transplante Cardíaco (INIBIC) | es_ES |
| UDC.institutoCentro | INIBIC - Instituto de Investigacións Biomédicas de A Coruña | es_ES |
| UDC.issue | 4 | es_ES |
| UDC.journalTitle | The American Journal of Cardiology | es_ES |
| UDC.startPage | 535 | es_ES |
| UDC.volume | 118 | es_ES |
| dc.contributor.author | Kaplon-Cieslicka, Agnieszka | |
| dc.contributor.author | Tyminska, Agata | |
| dc.contributor.author | Peller, Michal | |
| dc.contributor.author | Balsam, Pawel | |
| dc.contributor.author | Ozieranski, Krzysztof | |
| dc.contributor.author | Galas, Michalina | |
| dc.contributor.author | Marchel, Michal | |
| dc.contributor.author | Crespo-Leiro, María Generosa | |
| dc.contributor.author | Maggioni, Aldo P. | |
| dc.contributor.author | Drozdz, Jaroslaw | |
| dc.contributor.author | Filipiak, Krzysztof J. | |
| dc.contributor.author | Opolski, Grzegorz | |
| dc.date.accessioned | 2019-03-27T13:17:44Z | |
| dc.date.available | 2019-03-27T13:17:44Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | [Abstract] Compared with heart failure (HF) with reduced ejection fraction (HF-REF), the diagnosis of HF with preserved EF (HF-PEF) is more challenging. The aim of the study was to assess the prevalence of HF-PEF among patients hospitalized for HF, to evaluate the pertinence of HF-PEF diagnosis and to compare HF-PEF and HF-REF patients with respect to outcomes. The analysis included 661 Polish patients hospitalized for HF, selected from the European Society of Cardiology (ESC)-HF Long-Term Registry. Patients with an EF of ≥50% were included in the HF-PEF group and patients with an EF of <50% - in the HF-REF group. The primary end point was all-cause death at 1 year. The secondary end point was a composite of all-cause death and rehospitalization for HF at 1 year. HF-PEF was present in 187 patients (28%). Of those 187 patients, mitral inflow pattern was echocardiographically assessed in 116 patients (62%) and classified as restrictive/pseudonormal in 37 patients (20%). Compared with HF-REF subjects, patients with HF-PEF were older, more often female, and had a higher prevalence of hypertension, atrial fibrillation and sleep apnea. Despite lower B-type natriuretic peptide concentrations and lower prevalence of moderate-to-severe mitral regurgitation in patients with HF-PEF, congestive symptoms at admission were as severe as in patients with HF-REF. There were no significant differences in in-hospital mortality between the HF groups. One-year mortality was high in both groups (17% in HF-PEF vs 21% in HF-REF, p = 0.22). There was a trend toward a lower frequency of the secondary end point in the HF-PEF group (32% vs 40%, p = 0.07). In conclusion, in clinical practice, even easily obtainable echocardiographic indexes of diastolic dysfunction are relatively rarely acquired. One-year survival rate of patients with HF-PEF is not significantly better than that of patients with HF-REF. | es_ES |
| dc.identifier.citation | Kaplon-Cieslicka A, Tyminska A, Peller M, et al. Diagnosis, clinical course, and 1-year outcome in patients hospitalized for heart failure with preserved ejection fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry). Am J Cardiol. 2016; 118(4): 535-542 | es_ES |
| dc.identifier.issn | 0002-9149 | |
| dc.identifier.uri | http://hdl.handle.net/2183/22390 | |
| dc.language.iso | eng | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.relation.uri | https://doi.org/10.1016/j.amjcard.2016.05.046 | es_ES |
| dc.rights | Atribución-NoComercial-SinDerivadas 3.0 España | es_ES |
| dc.rights.accessRights | open access | es_ES |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
| dc.subject | Atrial fibrillation | es_ES |
| dc.subject | Comorbidity | es_ES |
| dc.subject | Disease progression | es_ES |
| dc.subject | Echocardiography | es_ES |
| dc.subject | Heart failure | es_ES |
| dc.subject | Hospital mortality | es_ES |
| dc.subject | Hospitalization | es_ES |
| dc.subject | Hypertension | es_ES |
| dc.subject | Natriuretic peptides | es_ES |
| dc.subject | Brain | es_ES |
| dc.subject | Severity of illness index | es_ES |
| dc.subject | Sleep apnea syndromes | es_ES |
| dc.subject | Stroke volume | es_ES |
| dc.subject | Poland | |
| dc.title | Diagnosis, clinical course, and 1-year outcome in patients hospitalized for heart failure with preserved ejection fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry) | es_ES |
| dc.type | journal article | es_ES |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | 36d178fd-10a0-48a2-925d-71d185a50eda | |
| relation.isAuthorOfPublication.latestForDiscovery | 36d178fd-10a0-48a2-925d-71d185a50eda |
Files
Original bundle
1 - 3 of 3
Loading...
- Name:
- KaplonCslska_Diagnosis.pdf
- Size:
- 597.18 KB
- Format:
- Adobe Portable Document Format
- Description:
Loading...
- Name:
- KaplonCslska_Diagnosis_Suppl_1.docx
- Size:
- 42.43 KB
- Format:
- Microsoft Word XML
- Description:
- Supplementary table 1
Loading...
- Name:
- KaplonCslska_Diagnosis_Suppl_2.docx
- Size:
- 40.92 KB
- Format:
- Microsoft Word XML
- Description:
- Supplementary table 2

